Table 1.
Assessment no | 1 | 2 | 3 | 4 | 5 | |
Assessment timing | Day −90 to 0 before surgery | Day 1 after surgery on ward | Day 2 after surgery on ward | Day 3 after surgery on ward | Day 30 after surgery +30 days to allow time to review postoperative investigations and supporting information | |
Clinical history | Assessment | |||||
Eligibility criteria | X | |||||
Informed consent | X | |||||
Demographics | X | |||||
Past medical history | X | |||||
Height | X | |||||
Weight | X | |||||
Surgery type | X | |||||
Laboratory tests | ||||||
Haemoglobin | X | |||||
Serum creatinine | X | |||||
BNP | X | |||||
Point-of-care NT-pro-BNP | X | |||||
hsTnI | X | X | X | |||
Clinical outcomes | ||||||
Death | X | |||||
Vascular death | X | |||||
MINS (including MI and isolated-ischaemic troponin elevation) | X | |||||
Stroke | X | |||||
Cardiac arrest | X | |||||
Major bleed | X | |||||
Congestive heart failure | X | |||||
Coronary artery revascularisation | X | |||||
Pulmonary embolus | X | |||||
Pneumonia | X | |||||
Sepsis | X | |||||
New atrial fibrillation | X |
BNP, B-type natriuretic peptide; hsTnI, high sensitivity troponin I; MI, myocardial infarction; MINS, myocardial injury after non-cardiac surgery; NT-pro-BNP, N-terminal pro-BNP.